» Articles » PMID: 19505458

Ovarian Steroids Alter Mu Opioid Receptor Trafficking in Hippocampal Parvalbumin GABAergic Interneurons

Overview
Journal Exp Neurol
Specialty Neurology
Date 2009 Jun 10
PMID 19505458
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

The endogenous hippocampal opioid systems are implicated in learning associated with drug use. Recently, we showed that ovarian hormones regulate enkephalin levels in the mossy fiber pathway. This pathway overlaps with parvalbumin (PARV)-basket interneurons that contain the enkephalin-activated mu opioid receptors (MORs) and are important for controlling the "temporal timing" of granule cells. Here, we evaluated the influence of ovarian steroids on the trafficking of MORs in PARV interneurons. Two groups of female rats were analyzed: cycling rats in proestrus (relatively high estrogens) or diestrus; and ovariectomized rats euthanized 6, 24 or 72 h after estradiol benzoate (10 microg, s.c.) administration. Dorsal hippocampal sections were dually immunolabeled for MOR and PARV and examined by light and electron microscopy. As in males, in females MOR-immunoreactivity (-ir) was in numerous PARV-labeled perikarya, dendrites and terminals in the dentate hilar region. Variation in ovarian steroid levels altered the subcellular distribution of MORs in PARV-labeled dendrites but not terminals. In normal cycling rats, MOR-gold particles on the plasma membrane of small PARV-labeled dendrites (area <1 microm2) had higher density in proestrus rats than in diestrus rats. Likewise, in ovariectomized rats MORs showed higher density on the plasma membrane of small PARV-labeled dendrites 72 h after estradiol exposure. The number of PARV-labeled cells was not affected by estrous cycle phase or estrogen levels. These results demonstrate that estrogen levels positively regulate the availability of MORs on GABAergic interneurons in the dentate gyrus, suggesting cooperative interaction between opioids and estrogens in modulating principal cell excitability.

Citing Articles

Divergent opioid-mediated suppression of inhibition between hippocampus and neocortex across species and development.

Caccavano A, Vlachos A, McLean N, Kimmel S, Kim J, Vargish G bioRxiv. 2024; .

PMID: 38313283 PMC: 10836073. DOI: 10.1101/2024.01.20.576455.


Mapping Astrocytic and Neuronal μ-opioid Receptor Expression in Various Brain Regions Using MOR-mCherry Reporter Mouse.

Won W, Kim D, Shin E, Lee C Exp Neurobiol. 2024; 32(6):395-409.

PMID: 38196135 PMC: 10789176. DOI: 10.5607/en23039.


Effects of prenatal opioid exposure on synaptic adaptations and behaviors across development.

Simmons S, Grecco G, Atwood B, Nugent F Neuropharmacology. 2022; 222:109312.

PMID: 36334764 PMC: 10314127. DOI: 10.1016/j.neuropharm.2022.109312.


GABA System Modifications During Periods of Hormonal Flux Across the Female Lifespan.

Gilfarb R, Leuner B Front Behav Neurosci. 2022; 16:802530.

PMID: 35783228 PMC: 9245048. DOI: 10.3389/fnbeh.2022.802530.


Sex differences in the rodent hippocampal opioid system following stress and oxycodone associated learning processes.

Chalangal J, Mazid S, Windisch K, Milner T Pharmacol Biochem Behav. 2021; 212:173294.

PMID: 34752798 PMC: 8748406. DOI: 10.1016/j.pbb.2021.173294.


References
1.
Derrick B, Rodriguez S, Lieberman D, Martinez Jr J . Mu opioid receptors are associated with the induction of hippocampal mossy fiber long-term potentiation. J Pharmacol Exp Ther. 1992; 263(2):725-33. View

2.
Backstrom T . Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand. 1976; 54(4):321-47. DOI: 10.1111/j.1600-0404.1976.tb04363.x. View

3.
Woolley C, McEwen B . Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci. 1994; 14(12):7680-7. PMC: 6576901. View

4.
Chan J, Aoki C, Pickel V . Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Methods. 1990; 33(2-3):113-27. PMC: 2845158. DOI: 10.1016/0165-0270(90)90015-8. View

5.
Herzog A, Harden C, Liporace J, Pennell P, Schomer D, Sperling M . Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol. 2004; 56(3):431-4. DOI: 10.1002/ana.20214. View